Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 24 of 24 entries
View as:
Phase: N/A
Priority: Normal
Start: 11/09/22
End: 01/31/27
Due: 01/31/28
Phase: N/A
Priority: Normal
Start: 08/24/23
End: 08/31/25
Due: 08/31/26
Phase: N/A
Priority: Normal
Start: 07/24/24
End: 09/30/25
Due: 09/30/26
Phase: N/A
Priority: Normal
Start: 10/02/23
End: 06/30/25
Due: 06/30/26
Phase: N/A
Priority: Normal
Start: 05/11/23
End: 01/31/26
Due: 01/31/27
Phase: N/A
Priority: Normal
Start: 01/18/24
End: 02/28/27
Due: 02/28/28
Phase: N/A
Priority: Normal
Start: 04/30/16
End: 12/31/16
Due: 12/31/17
Phase: N/A
Priority: Normal
Start: 12/01/16
End: 02/28/20
Due: 02/28/21
Phase: N/A
Priority: Normal
Start: 11/06/24
End: 03/31/25
Due: 03/31/26
Phase: N/A
Priority: Normal
Start: 01/01/24
End: 07/01/26
Due: 07/01/27
Phase: N/A
Priority: Normal
Start: 01/08/19
End: 12/31/21
Due: 12/31/22
Phase: N/A
Priority: Normal
Start: 12/10/20
End: 11/30/28
Due: 11/30/29
Phase: N/A
Priority: Normal
Start: 01/31/25
End: 04/30/27
Due: 04/30/28
Phase: N/A
Priority: Normal
Start: 09/10/24
End: 10/31/26
Due: 10/31/27
Phase: N/A
Priority: Normal
Start: 10/01/23
End: 09/30/27
Due: 09/30/28
Phase: N/A
Priority: Normal
Start: 10/02/23
End: 01/31/25
Due: 01/31/26
Phase: N/A
Priority: Normal
Start: 10/02/23
End: 02/28/25
Due: 02/28/26
Phase: N/A
Priority: Normal
Start: 03/15/18
End: 12/31/19
Due: 12/31/20
Phase: N/A
Priority: Normal
Start: 11/05/18
End: 05/21/20
Due: 05/21/21
Phase: N/A
Priority: Normal
Start: 01/27/25
End: 03/31/26
Due: 03/31/27
Phase: N/A
Priority: Normal
Start: 12/27/21
End: 03/19/23
Due: 03/19/24
Phase: N/A
Priority: Normal
Start: 10/26/21
End: 12/31/26
Due: 12/31/27
Clinical Safety Study on 5-Aminolevulinic Acid (5-ALA) in Children and Adolescents With Brain Tumors
Phase: N/A
Priority: Normal
Start: 09/25/20
End: 06/30/25
Due: 06/30/26
Phase: N/A
Priority: Normal
Start: 03/13/25
End: 10/31/28
Due: 10/31/29